Dax drops below 14,000 points

Sell-off on the German stock market: The Dax fell sharply on Tuesday morning. The main reason for this is the expected inflation data in the United States.

Ahead of important inflation data from the United States, pressure on the German stock market increased markedly on Tuesday. The Dax slipped below 14,000 points for the first time since mid-March upon opening. More recently, the main German index lost 1.91% to 13,922 points. The previous week he had managed to stay just above the lap mark.

The MDAX MDAX index fell 1.37% to 30,154 points in the first hour of trading. The flagship index of the euro zone EuroStoxx 50 EuroStoxx50 Index fell 1.8%. The day before, the sell-off of technology stocks had already continued in the United States with the rise in bond yields. In the morning, Asian stock markets mostly recorded losses.

US consumer prices likely rose further in March to a 40-year high, Helaba experts suspect. “In this regard, the Fed will feel confirmed in its intention to raise its key rates several times this year. Whether the already ambitious interest rate expectations will continue to be pushed remains to be seen.”

Deutsche Bank shares fall

The war in Ukraine and global supply chain issues, recently exacerbated by new Covid outbreaks and lockdowns in China, are pushing inflation higher, so central banks are under pressure to tighten monetary policy further. – with corresponding negative consequences for stock markets.

Another important leading indicator will also be released in the morning with the German ZEW Economic Expectations. Economists expect sentiment to decline further after expectations among financial market participants fell at an unprecedented pace the previous month due to the war in Ukraine and sanctions against Russia.

In the Dax, almost all stocks posted losses in the morning, and Deutsche Bank was affected Deutsche Bank Shares worse with a less than more than ten percent. Commerzbank falls in the MDax Commerzbank Stock nearly nine percent. The reason is a sale of large blocks of shares by an investor, as reported by the Bloomberg news agency.

Few titles with small profits

Symrise Share Symrise fight in Dax according to the figures of the competitor Givaudan Givaudan shares from Switzerland with a discount of 0.2% significantly higher than that of the market as a whole. Givaudan performed slightly better than expected, analysts said.

Evotec Evotec share were subject to fluctuations in terms of numbers and outlook. More recently they were 0.6% lower in the MDax, but this contained their previously larger minus somewhat. A trader described the drug researcher’s current year forecast as mixed.

The titles of the drug manufacturer Dermapharm Dermapharm Holding stock among the favorites of the SDax small cap index, benefited from a significant increase in the dividend with a price increase of 0.4%.

Leave a Comment